A1I6Z
Zidesamtinib
| Created: | 2025-03-19 |
| Last modified: | 2025-04-30 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 53 |
| Chiral Atom Count | 1 |
| Bond Count | 57 |
| Aromatic Bond Count | 22 |
Chemical Component Summary | |
|---|---|
| Name | Zidesamtinib |
| Formula | C22 H22 F N7 O |
| Molecular Weight | 419.455 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CCn1ncc2Cc3nn(C)nc3c4ccc(F)cc4[CH](C)Oc5cc(cnc5N)c12 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CCn1c-2c(cn1)Cc3c(nn(n3)C)-c4ccc(cc4C(Oc5cc2cnc5N)C)F |
| Canonical SMILES | CACTVS | 3.385 | CCn1ncc2Cc3nn(C)nc3c4ccc(F)cc4[C@@H](C)Oc5cc(cnc5N)c12 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CCn1c-2c(cn1)Cc3c(nn(n3)C)-c4ccc(cc4[C@H](Oc5cc2cnc5N)C)F |
| InChI | InChI | 1.06 | InChI=1S/C22H22FN7O/c1-4-30-21-13(11-26-30)7-18-20(28-29(3)27-18)16-6-5-15(23)9-17(16)12(2)31-19-8-14(21)10-25-22(19)24/h5-6,8-12H,4,7H2,1-3H3,(H2,24,25)/t12-/m1/s1 |
| InChIKey | InChI | 1.06 | DTWUUAFTYSMNQX-GFCCVEGCSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB21623 |
|---|---|
| Name | Zidesamtinib |
| Groups | investigational |
| Description | Zidesamtinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Zidesamtinib is a tyrosine kinase inhibitor. Zidesamtinib is under investigation in clinical trial NCT06797362 (Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors). Zidesamtinib has a monoisotopic molecular weight of 419.19 Da. |
| Synonyms | Zidesamtinib |
| CAS number | 2739829-00-4 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 166560233 |
| ChEMBL | CHEMBL5314497 |
